Genomic Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common Stock, par value $0.0001 per
share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo Kirby
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
|
||||
February 10, 2010
|
||||
(Date
of Event which Requires Filing of this Statement)
|
CUSIP No. 37244C101
|
Page
2
of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian C.
Baker
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a) ¨
(b) ¨
|
3
|
SEC
USE ONLY
|
|
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT
TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
33,000
|
8
|
SHARED
VOTING POWER
6,097,613
|
|
9
|
SOLE
DISPOSITIVE POWER
33,000
|
|
10
|
SHARED
DISPOSITIVE POWER
6,097,613
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,130,613
|
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
¨
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
21.4%
|
|
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 37244C101
|
Page
3
of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix J. Baker
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a) ¨
(b) ¨
|
3
|
SEC
USE ONLY
|
|
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT
TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
8
|
SHARED
VOTING POWER
6,097,613
|
|
9
|
SOLE
DISPOSITIVE POWER
0
|
|
10
|
SHARED
DISPOSITIVE POWER
6,097,613
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,097,613
|
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
¨
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
21.3%
|
|
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Item
5.
|
Interest
in Securities of the Issuer.
|
Name
|
Number of
Shares
|
Percent of Class
Outstanding
|
||||||
Baker
Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker
Bros. Investments II, L.P.
|
20,287 | 0.1 | % | |||||
667,
L.P.
|
1,253,653 | 4.4 | % | |||||
Baker
Brothers Life Sciences, L.P.
|
4,168,674 | 14.5 | % | |||||
14159,
L.P.
|
113,044 | 0.4 | % | |||||
FBB
Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch
Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian
C. Baker
|
33,000 | 0.1 | % | |||||
Total
|
6,130,613 | 21.4 | % |
Number of
|
||||||||
Name
|
Date
|
Shares
|
Transaction
|
Price / Share
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/8/2010
|
43,291
|
Purchase
|
16.8521
|
||||
14159,
L.P.
|
2/8/2010
|
1,195
|
Purchase
|
16.8521
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/8/2010
|
7,975
|
Purchase
|
16.9311
|
||||
14159,
L.P.
|
2/8/2010
|
220
|
Purchase
|
16.9311
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/8/2010
|
21,703
|
Purchase
|
16.8741
|
||||
14159,
L.P.
|
2/8/2010
|
599
|
Purchase
|
16.8741
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/9/2010
|
13,943
|
Purchase
|
17.0261
|
||||
14159,
L.P.
|
2/9/2010
|
385
|
Purchase
|
17.0261
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/9/2010
|
1,070
|
Purchase
|
16.9323
|
||||
14159,
L.P.
|
2/9/2010
|
30
|
Purchase
|
16.9323
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/9/2010
|
21,979
|
Purchase
|
17.1522
|
||||
14159,
L.P.
|
2/9/2010
|
607
|
Purchase
|
17.1522
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/10/2010
|
223,822
|
Purchase
|
17.0414
|
||||
14159,
L.P.
|
2/10/2010
|
6,178
|
Purchase
|
17.0414
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/10/2010
|
7,100
|
Purchase
|
16.9294
|
||||
14159,
L.P.
|
2/10/2010
|
196
|
Purchase
|
16.9294
|
||||
Baker
Brothers Life Sciences, L.P.
|
2/10/2010
|
971
|
Purchase
|
16.9773
|
||||
14159,
L.P.
|
|
2/10/2010
|
|
27
|
|
Purchase
|
|
16.9773
|
Item
6.
|
Contracts,
Arrangements, Understandings or Relationships with Respect to Securities
of the Issuer.
|
Item
7.
|
Material
to Be Filed as Exhibits.
|
Exhibit
1.
|
Agreement
regarding the joint filing of this
statement.
|
By:
|
/s/ Julian C. Baker
|
|
Julian
C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix
J. Baker
|
By:
|
/s/ Julian C. Baker
|
|
Julian
C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix
J. Baker
|